Catheter ablation (CA) has become an established treatment strategy for managing recurrent ventricular tachycardias (VTs) in patients with structural heart disease. In recent years, percutaneous mechanical circulatory support (PMCS) devices have been increasingly used intra-operatively to improve the ablation outcome. One indication would be rescue therapy for patients who develop haemodynamic deterioration during the ablation. However, more efforts are focused on identifying subjects who are at high risk of such deterioration and could benefit from the pre-emptive use of the PMCS. The third reason to use PMCS could be the inability to identify diffuse substrate, especially in non-ischaemic cardiomyopathy. This paper reviews available experiences using various types of PMCS in different clinical scenarios. Although PMCS allows mapping during VT, it does not significantly influence acute outcomes and not convincingly long-term outcomes. On the contrary, the complication rate appears to be higher in PMCS cohorts. Our data suggest that even in patients with severe left ventricular dysfunction, the substrate modification can be performed without the need for general anaesthesia and risk of haemodynamic decompensation. In end-stage heart failure associated with the electrical storm, implantation of a left ventricular assist device (or PMCS with a transition to the left ventricular assist device) might be the preferred strategy before CA. In high-risk patients who are not potential candidates for these treatment options, radiotherapy could be considered as a bail-out treatment of recurrent VTs. These approaches should be studied in prospective trials.

Department of Cardiology Institute for Clinical and Experimental Medicine Vídeňská 1958 9 Prague 140 21 Czech Republic

Department of Internal Medicine 1 Cardiology Palacký University Medical School Olomouc Czech Republic

Zobrazit více v PubMed

Mallidi  J, Nadkarni  GN, Berger  RD, Calkins  H, Nazarian  S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm  2011;8:503–10. PubMed PMC

Aldhoon  B, Wichterle  D, Peichl  P, Cihak  R, Kautzner  J. Outcomes of ventricular tachycardia ablation in patients with structural heart disease: the impact of electrical storm. PLoS One  2017;12:e0171830. PubMed PMC

Da Silva  GL, Nunes-Ferreira  A, Cortez-Dias  N, de Sousa  J, Pinto  FJ, Caldeira  D. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol  2020;59:603–16. PubMed

Garcia  JG, Arya  A, Dinov  B, Bollmann  A, Ter Bekke  RMA, Vernooy  K  et al.  Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease. Europace  2023;26:euad367. PubMed PMC

Mariani  S, Napp  LC, Lo Coco  V, Delnoij  TSR, Luermans  JGLM, ter Bekke  RMA  et al.  Prophylactic mechanical support for protected ventricular tachycardia ablation. Int J Cardiol  2020;308:42–9. PubMed

Zanobini  M, Rossi  F, Bertera  A, Sandano  S, Costa  C, Fabrizi  R  et al.  Cardiopulmonary support during electrophysiological procedures for ventricular tachycardias not haemodynamically tolerated. Perfusion  2003;18:79–82. PubMed

Carbucicchio  C, Della Bella  P, Fassini  G, Trevisi  N, Riva  S, Giraldi  F  et al.  Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients. Herz  2009;34:545–52. PubMed

Miller  MA, Dukkipati  SR, Mittnacht  A, Chinitz  JS, Belliveau  L, Koruth  JS  et al.  Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll CArdiol  2011;58:1363–71. PubMed

Bunch  RJ, Darby  A, May  HT, Ragosta  M, Lim  DS, Taylor  AM  et al.  Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace  2012;14:709–14. PubMed PMC

Miller  MA, Dukkipati  SR, Chinitz  JS, Koruth  JS, Mittnacht  AJ, Napolitano  C  et al.  Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol  2013;6:151–6. PubMed

Lu  F, Eckman  PM, Liao  KK, Apostolido  I, John  R, Chen  T  et al.  Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol  2013;168:3859–65. PubMed

Aryana  A, O’Neill  G, Gregory  D, Scotti  D, Bailey  S, Brunton  S  et al.  Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm  2014;11:1122–30. PubMed

Baratto  F, Pappalardo  F, Oloriz  T, Bisceglia  C, Vergara  P, Silberbauer  J  et al.  Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Arrhythm Electrophysiol  2016;9:e004492. PubMed

Turagam  MK, Vuddanda  V, Atkins  D, Santangeli  P, Frankel  DS, Tung  R  et al.  Hemodynamic support in ventricular tachycardia ablation: an international VT ablation center collaborative group study. JACC Clin Electrophysiol  2017;26:1534–43. PubMed

Mathuria  N, Wu  G, Rojas-Delgado  F, Shuraih  M, Razavi  M, Civitello  A  et al.  Outcomes of pre-emptive and rescue use of left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol  2017;48:27–34. PubMed

Kusa  S, Miller  MA, Whang  W, Enomoto  Y, Panizo  JG, Iwasawa  J  et al.  Outcome of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhyt Electrophysiol  2017;10:e004717. PubMed

Muser  D, Liang  JJ, Castro  SA, Hayashi  T, Enriquez  A, Troutman  GS  et al.  Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm  2018;15:1500–6. PubMed

Enriquez  A, Liang  J, Gentile  J, Schaller  R, Supple  G, Frankel  DS  et al.  Outcomes of rescue cardiopulmonary support for periprocedural hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm  2018;15:75–80. PubMed

Di Monaco  A, Quadrini  F, Troisy  F, Vitulano  N, Caruso  R, Duni  N  et al.  Cardiopulmonary support in patients undergoing catheter ablation of poorly tolerated ventricular arrhythmias and electrical storm. J Cardiovasc Electrophysiol  2019;30:1281–6. PubMed

Neuzner  J, Dietze  T, PAliege  R, Gradaus  R. Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advance heart failure patients: a retrospective single-center analysis. J Cardiac Electrophysiol  2019;30:2864–8. PubMed

Ballout  JA, Wazni  OM, Tarakji  KG, Saliba  WI, Kanj  M, Diab  M  et al.  Catheter ablation in patients with cardiogenic shock and refractory ventricular tachycardia. Circ Arrhythm Electrophysiol  2020;13:e007669. PubMed PMC

Grimaldi  M, Marino  MM, Vitulano  N, Quadrini  F, Troisi  F, Caporusso  N  et al.  Cardiopulmonary support during catheter ablation of ventricular arrhythmias with hemodynamic instability: the role of inducibility. Front Cardiovasc Med  2021;8:747858. PubMed PMC

Chen  Q, Pollet  M, Mehta  A, Wang  S, Dean  J, Parenti  J  et al.  Delayed removal of a percutaneous left ventricular assist device for patients undergoing catheter ablation of ventricular tachycardia is associated with increased 90-day mortality. J Interv Card Electrophysiol  2021;62:49–56. PubMed

Friedman  PA, Munger  TM, Torres  N, Rihal  C. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory. J Cardiovasc Electrophysiol  2007;18:106–9. PubMed

Aryana  A, d’Avila  A, Cool  CL, Miller  MA, Garcia  FC, Supple  GE  et al.  Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: an analysis of the Medicare database. J Cardiovasc Electrophysiol  2017;28:1295–302. PubMed

Santangeli  P, Rame  JE, Birati  EY, Marchlinski  FE. Management of ventricular arrhythmias in patients with advanced heart failure. J Am Coll Cardiol  2017;69:1842–960. PubMed

Turagam  MK, Vuddanda  V, Koerber  S, Garg  J, Yarlagadda  B, Dar  T  et al.  Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis. J Interv Cardiac Electrophysiol  2019;55:197–205. PubMed

Mariani  S, Napp  JC, Kraaier  K, Li  T, Bounader  K, Hanke  JS  et al.  Prophylactic mechanical circulatory support for protected ventricular tachycardia ablation: a meta-analysis of the literature. Artif Organs  2021;45:987–97. PubMed

Luni  FK, Zungsontiporn  N, Farid  T, Malik  SA, Khan  S, Daniels  J  et al.  Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: a meta-analysis of current evidence. J Cardiovasc Electrophysiol  2019;30:886–95. PubMed

Stojadinovic  P, Wichterle  D, Peichl  P, ČIhák  R, Aldhoon  B, Borišincová  E  et al.  Periprocedural acute hemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event. Europace  2024;26:euae145. PubMed PMC

Cuculich  PS, Schill  MR, Kashani  R, Mutic  S, Lang  A, Cooper  D  et al.  Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med  2017;377:2325–36. PubMed PMC

Neuwirth  R, Cvek  J, Knybel  L, Jiravsky  O, Molenda  L, Kodaj  M  et al.  Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace  2019;21:1088–195. PubMed

Jumeau  R, Ozsahin  M, Schwitter  J, Vallet  V, Duclos  F, Zeverino  M  et al.  Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol  2018;128:189–91. PubMed

Ninni  S, Gallot-Lavallée  T, Klein  C, Longere  B, Brigadeau  F, Potelle  C  et al.  Stereotactic radioablation for ventricular tachycardia in the setting of electrical storm. Circ Arrhythm Electrophysiol  2022;15:e010955. PubMed

Wight  J, Bigham  T, Schwartz  A, ZAhid  AT, Bhatia  N, Kiani  S  et al.  Long term follow-up of stereotactic body radiation therapy for refractory ventricular tachycardia in advanced heart failure patients. Front Cardiovasc Med  2022;9:849113. PubMed PMC

Hašková  J, Wichterle  D, Kautzner  J, Šramko  M, Peichl  P, Jiravský  O  et al.  Efficacy and safety of stereotactic radiotherapy in patients with recurrent ventricular tachycardias: the Czech experience. JACC Clin Electrophysiol  2024;10:654–66. PubMed

Benali  K, Higgins  K, Quivrin  M, Bessieres  I, WIght  JA, Gupta  D  et al.  Cardiac stereotactic radiation therapy for refractory ventricular arrhythmias in patients with left ventricular assist device. JACC Clin Electrophysiol  2023;9:707–9. PubMed

Benali  K, LLoyd  MS, Petrosyan  A, Rigal  L, Quivrin  M, Bessieres  I  et al.  Cardiac stereotactic radiation therapy for refractory ventricular arrhythmias in patients with left ventricular assist devices. J Cardiovasc Electrophysiol  2024;35:206–13. PubMed

Kumar  S, Baldinger  SH, Romero  J, Fujii  A, Mahida  SN, Tedrow  UB  et al.  Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis. J Cardiovasc Electrophysiol  2016;27:1437–47. PubMed

Pourdjabbar  A, Maze  R, Hibbert  B, Ruel  M, Haddad  H. Left ventricular assist device in the management of refractory electrical storm. Perfusion  2015;30:302–4. PubMed

Tsai  FC, Wang  YC, Huang  YK, Tseng  SN, Wu  MY, Chang  Y-S  et al.  Extracorporal life support to terminate refractory ventricular tachycardia. Crit Care Med  2007;35:1673–6. PubMed

Kulick  DM, Bolman  ME  III, Salerno  CT, Bank  AJ, Park  SJ. Management of recurrent ventricular tachycardia with ventricular assist device placement. Ann Thorac Surg  1998;66:571–3. PubMed

Fasseas  P, Kutalek  SP, Samuels  FL, Holmes  EC, Samuels  LE. Ventricular assist device support for management of sustained ventricular arrhythmias. Texas Heart Inst J  2002;29:33–6. PubMed PMC

Efimova  E, Fischer  J, Bertagnolli  L, Dinov  B, Kircher  S, Rolf  S  et al.  Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study. Heart Rhythm  2017;14:1812–9. PubMed

Moss  JD, Flatley  EE, Beaser  AD, Shin  JH, Nayak  HM, Upadhyay  GA  et al.  Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. J Am Coll Cardiol EP  2017;3:1412–24. PubMed

Galand  V, Flecher  E, Auffret  V, Pichard  C, Boulé  S, Vincentelli  A  et al.  Early ventricular arrhythmias after LVAD implantation is the strongest predictor of 30-day post-operative mortality. J Am Coll Cardiol  2019;5:944–54. PubMed

Martins  RP, Leclercq  C, Bourenane  H, Auffret  V, Boulé  S, Loobuyck  V  et al.  Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: new insights from the ASSIST-ICD study. Heart Rhythm  2019;16:1506–12. PubMed

Karikalan  S, Tan  MC, Zhang  N, El-Masr  H, Killu  AM, DeSimone  CV  et al.  Electrical storm after left ventricular assist device (LVAD) implantation. J Cardiovasc Electrophysiol  2024;35:1196–202. PubMed

Rehorn  MR, Black-Maier  E, Loungani  R, Sen  S, Sun  AY, Friedman  DJ  et al.  Electrical storm in patients with left ventricular assist devices: risk factors, incidence, and impact on survival. Heart Rhythm  2021;18:1263–71. PubMed

Patel  M, Rojas  F, Shabari  FR, Simpson  L, Cohn  W, Frazier  OH  et al.  Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation. J Cardiovasc Electrophysiol  2016;27:95–101. PubMed

Moss  JD, Oesterle  A, Raiman  M, Flatley  EE, Beaser  AD, Jeevanandam  V  et al.  Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol  2019;30:183–92. PubMed

Huang  DT, Gosev  I, Wood  KL, Vidula  H, Stevenson  W, Marchlinski  F  et al.  Design and characteristics of the prophylactic intra-operative ventricular arrhythmia ablation in high-risk LVAD candidates (PIVATAL) trial. Noninvasive Electrocardiol  2023;28:e13073. PubMed PMC

Sacher  F, Reichlin  T, Zado  ES, Field  ME, Viles-Gonzalez  JF, Peichl  P  et al.  Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol  2015;8:592–7. PubMed

Anderson  RD, Lee  G, Virk  S, Bennett  RG, Hayward  CS, Muthiah  K  et al.  Catheter ablation of ventricular tachycardia in patients with a ventricular assist device: a systematic review of procedural characteristics and outcomes. JACC Clin Electrophysiol  2019;5:39–51. PubMed

Tseng  YD, Gouwens  NW, Lo  SS, Halasz  LM, Spady  P, Mezheritsky  IA  et al.  Use of radiation therapy within the last year of life among cancer patients. Int J Radiat Oncol Biol Phys  2018;101:21–9. PubMed

Spencer  K, Parrish  R, Barton  R, Henry  A. Palliative radiotherapy. BMJ  2018;360:k821. PubMed PMC

Pothineni  NVK, Enriques  A, Kumareswaran  R, Garcia  F, Shah  R, Wald  J  et al.  Outcomes of a PAINESD score-guided multidisciplinary management approach for patients with ventricular tachycardia storm and advanced heart failure: a pilot study. Heart Rhythm  2023;20:134–9. PubMed